Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Lupus Vulgaris

Known as: Lupus, Lupus Vulgaris [Disease/Finding], lupus tuberculosis 
A form of cutaneous tuberculosis. It is seen predominantly in women and typically involves the NASAL MUCOSA; BUCCAL MUCOSA; and conjunctival mucosa.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
The heterogeneity of systemic lupus erythematosus (SLE), long recognised by clinicians, is now challenging the entire lupus… Expand
Is this relevant?
Review
2019
Review
2019
Our objective was to update the EULAR recommendations for the management of systemic lupus erythematosus (SLE), based on emerging… Expand
Is this relevant?
Review
2015
Review
2015
  • M. A. A. Al-Bari
  • The Journal of antimicrobial chemotherapy
  • 2015
  • Corpus ID: 12005445
Antimalarial drugs (e.g. chloroquine and its close structural analogues) were developed primarily to treat malaria; however, they… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Tuberculosis (TB), caused by infection with Mycobacterium tuberculosis, is a major cause of morbidity and mortality worldwide… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Serious concerns have been raised about the ecological effects of industrialized fishing, spurring a United Nations resolution on… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Dendritic cells (DCs) are important in regulating both immunity and tolerance. Hence, we hypothesized that systemic lupus… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
A registry of United States residents with chronic granulomatous disease (CGD) was established in 1993 in order to estimate the… Expand
Is this relevant?
Highly Cited
1999
Highly Cited
1999
BACKGROUND & AIMS Infliximab, an anti-tumor necrosis factor monoclonal antibody, rapidly reduces signs and symptoms of active… Expand
Is this relevant?
Highly Cited
1992
Highly Cited
1992
OBJECTIVE To standardize outcome measures in systemic lupus erythematosus (SLE). Three indices were identified which could… Expand
Is this relevant?
Highly Cited
1977
Highly Cited
1977
A radioimmunoassay for ng quantities of DNA was developed. [125l]lododeoxyuridine-labeled DNA was used as the antigen, and the… Expand
  • table 1
  • table 3
Is this relevant?